New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
09:16 EDTCONXCorgenix Medical announces CE Mark notification for TxBCardio assay
Corgenix Medical Corporation announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio Assay. The TxBCardio test measures urinary levels of the thromboxane metabolite 11dhTxB2 to determine aspirin effect in apparently healthy individuals. CE mark designation enables commercial marketing and distribution of the product in Europe.
News For CONX From The Last 14 Days
Check below for free stories on CONX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
08:02 EDTCONXCorgenix Medical to be acquired by Orgentec Diagnostika for $16M
Corgenix Medical Corporation announced that it has entered into a definitive merger agreement to be acquired by Orgentec Diagnostika, a specialty diagnostics company headquartered in Mainz, Germany. The strategic acquisition will extend both companies’ global distribution network and broaden their portfolio of specialty diagnostic assays. Under the terms of the agreement, which has been approved unanimously by Corgenix’s Board of Directors, Corgenix shareholders will receive 27c in cash for each share of common stock they own, in a transaction valued at approximately $16M. The per-share price represents a 29% premium to the Corgenix average share price of 21c over the 90-day period prior to the company’s announcement on March 12, that it was exploring strategic alternatives. The transaction is subject to approval by Corgenix shareholders and other customary closing conditions, and is expected to close in the fourth calendar quarter of 2014.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use